APR 03, 2020 7:31 AM PDT

Trial Drug Successfully Blocks COVID-19 from Entering Cells

WRITTEN BY: Annie Lennon

An international team led by Canadian University of British Columbia researcher Dr. Josef Penninger has seen promising results from a trial drug capable of blocking the cellular doors typically exploited by COVID-19 to infect multiple human organs. 

In earlier work, Penninger and colleagues form the University of Vienna and the University of Toronto identified ACE2, an enzyme that attaches to the outer surfaces of cells in the lungs, arteries, heart, kidney and intestines, as a key receptor for SARS, considered as a global viral respiratory threat back in 2003. As the previous form of SARS is closely related to the present COVID-19 (SARS-CoV-2), the researchers suspected that a similar mechanism may be at play for COVID-19 too. 

To test this, they infected engineered replicas of human blood vessels and kidneys, organoids grown from human stem cells, with COVID-19. Seeing that the virus was able to directly affect and duplicate itself in these tissues, they then used a drug, known as APN01 (human recombinant soluble angiotensin-converting enzyme 2- hrsACE2) to tackle its spread. Ultimately, the researchers found that the drug managed to inhibit the COVID-19’s viral load in these tissues by a factor of 1,000- 5,000. 

Showing both how the virus may lead to multiple organ failure and how a potential new treatment option may work, Nuria Monserrat, one of the study’s authors said, “Using organoids allows us to test in a very agile way treatments that are already being used for other diseases, or that are close to being validated. In these moments in which time is short, human organoids save the time that we would spend to test a new drug in the human setting.”

Soon to enter clinical trials by the European biotechnology firm Apeiron Biologics, Penninger said, “Our previous work has helped to rapidly identify ACE2 as the entry gate for SARS-CoV-2, which explains a lot about the disease. Now we know that a soluble form of ACE2 that catches the virus away, could be indeed a very rational therapy that specifically targets the gate the virus must take to infect us. There is hope for this horrible pandemic."

 

Sources: Science Daily, News Hub

 

 

About the Author
Other
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JAN 03, 2023
Immunology
An Antibody 'Decoy' Could Pave the Way for Better Immunotherapy
An Antibody 'Decoy' Could Pave the Way for Better Immunotherapy
Immunotherapy called CAR T cell therapy is a treatment that aims to train immune cells to get better at fighting disease ...
JAN 05, 2023
Cannabis Sciences
The New Medical Marijuana and Cannabidiol Research Expansion Act
The New Medical Marijuana and Cannabidiol Research Expansion Act
New legislation is going to open up opportunities to research cannabis and its potential health benefits. Here are the d ...
JAN 06, 2023
Drug Discovery & Development
Shellfish - the new method to prevent unwanted pregnancies
Shellfish - the new method to prevent unwanted pregnancies
A sugar that is created by shellfish may be the next best way to prevent unwanted pregnancies.  According to a 2022 ...
JAN 07, 2023
Coronavirus
Four Major Types of Long COVID Emerge
Four Major Types of Long COVID Emerge
Even mild cases of COVID-19 can lead to long COVID, in which symptoms linger for weeks, months, or longer, significantly ...
JAN 19, 2023
Drug Discovery & Development
Newest Treatment for Rosacea: Encapsulated Benzoyl Peroxide Cream
Newest Treatment for Rosacea: Encapsulated Benzoyl Peroxide Cream
Rosacea is a dermatologic condition affecting the centrofacial region (cheeks, chin, nose, and forehead), resulting ...
JAN 24, 2023
Technology
Using AI to triage chest pain patients
Using AI to triage chest pain patients
Experiencing chest pain can be alarming. In almost every case, the medical recommendation for people experience chest pa ...
Loading Comments...